A leading pharmaceutical company in Latin America, with strong hospital segment leadership, is driving growth through biosimilars, especially monoclonal antibodies, and expanding production capacity and international presence. Strategic investments and robust governance support its ambition for global reach.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.